Indian Pharmas See Emerging Markets Source Of Strong Sales Growth
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers are looking to Russia, Brazil and other emerging markets for sales potential as U.S. sales decline. Companies such as Ranbaxy Laboratories and Glenmark have been experiencing strong growth in the emerging markets, particularly last December. Glenmark cited Asia, Africa and the former states of the Soviet Union as sources of a 60 percent increase in sales to counter the 14 percent decline in overall revenues in the fourth quarter. (Click here for more